The House's Committee on Appropriations has added language to an FDA spending bill to prevent funds from being used to even evaluate germline editing experiments.
Bio-Rad scientist Jennifer Berman explains how ddPCR can help detect the basic efficiency of CRISPR/Cas9 and other genome editing technologies and more.
The scientists will use gut-on-a-chip technology to develop probiotics that can sense and respond to pathogenic microbes that have made their way into a person's GI system.
The pipeline identifies interesting mutants with PCR and sequencing and allows the creation of multiplexed mutants.
Doudna and Baltimore lead a group of experts tasked with identifying issues to address at an international summit on human gene editing and a subsequent study.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.